Cellular senescence, cancer and aging Buck Institute for Age Research Lawrence Berkeley National Laboratory September 10, 2005 SENS2, Cambridge.

Slides:



Advertisements
Similar presentations
Cancer—Principles and overview By Robert A. Weinberg
Advertisements

Cell Fate Quiescence Proliferation Differentiation Senescence Apoptosis Necrosis Cell states are mutually exclusive.
Chapter 19 Lecture Concepts of Genetics Tenth Edition Cancer and Regulation of the Cell Cycle.
P53, Apoptosis, Cancer, More Regulation G1 checkpoint Controlled by G1 Cdk-cyclin G1 cyclin levels also vary with the cell cycle Many additional levels.
Aging and Cancer: the Double-edged sword of cellular senescence And How to teach an old cell new tricks! Lawrence Berkeley National Laboratory and Buck.
Replicative aging in budding yeast cells Dr. Michael McMurray Dept. Molecular & Cell Biology.
3 Aging 1950 ’ s – Believed that cultivated cells could grow forever If not, then it was a result of a culturing deficiency – In 1943, a cancer cell.
PROLIFERAZIONE CELLULARE E RESISTENZA AI FARMACI.
Cancer Biology. 2 Outline 1.How do cancer cells differ from normal cells? Tumor progression Molecular basis for cancer.
Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
34 Cancer.
MDM2: Oncogene Chan Lee. Discovery of MDM2: starting with tumor suppressor p53.
MCB 135K Discussion February 2, Topics Functional Assessment of the Elderly Biomarkers of Aging Cellular Senescence –Lecture PowerPoint to be posted.
Hallmarks of Cancer Six fundamental changes 1.Self sufficiency in growth factors 2.Insensitivity to growth-inhibitory signals 3.Evasion of apoptosis 4.Limitless.
Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
When mammalian cells are subjected to stress signals, oxygen deficiency, radiation, DNA damage, or Chemo- therapeutic drugs, p53 is activated, leading.
Molecular Biology of Cancer What are the environmental influences that are cancer-causing? What is the difference between an oncogene and a proto-oncogene?
DNA Damage, Aging, and Cancer From Age-related and Telomere Concept.
Tumor genetics Minna Thullberg
NOTES: CH 18 part 2 - The Molecular Biology of Cancer
Tumorigenesis and Cancer Development Pin Ling ( 凌 斌 ), Ph.D. ext 5632; References: 1.Chapter 23 Cancer in “Molecular Cell Biology”
Cellular Senescence: A Link between Tumor Suppression and Organismal Aging.
Tumorigenesis to Cancer Development Pin Ling ( 凌 斌 ), Ph.D. ext 5632; References: 1.Chapter 23 Cancer in “Molecular Cell Biology”
Apoptosis (Programmed Cell Death). Apoptosis vs Necrosis Level of stress, change in environment stress apoptosisnecrosis.
Oncogenes, Tumor Suppressors, and the Cell Cycle Radiobiology 2012.
Diseases of aging A&S Jim Lund There is still no cure for the common birthday. -John Glenn Assigned reading: Chapter 8, Handbook of Aging 5th ed.
Characteristics of Cancer. Promotion (reversible) Initiation (irreversible) malignant metastases More mutations Progression (irreversible)
Development and Validation of an In Vitro Model for Osteoblast Aging: Beta- galactosidase and Acridine Orange Andrew Rosenzweig, MD Lab Meeting
23.1 Cancer Is a Group of Diseases Characterized by Cell Proliferation.
David Gius, M.D., Ph.D. Professor, Departments of Cancer Biology, Pediatrics, and Radiation Oncology Vanderbilt University School of Medicine Sirtuin 3:
BRCA1: Tumor Suppression and Breast Cancer A breast cancer cell dividing.
Regulation of Gene Expression. You Must Know The functions of the three parts of an operon. The role of repressor genes in operons. The impact of DNA.
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
Essentials of Biology Sylvia S. Mader
BRG-1 in Cancer BRG-1 is an ATPase subunit of the SWI/SNF class of chromatin remodeling complexes It has been found mutated in a number of cancer cell.
Cell Cycle Stages cells pass through from 1 cell division to the next.
Benign Versus Malignant Tumors
Section S Tumor viruses and oncogenes
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
Cells Tissues Organs Systems Organism ADAPTATIONS Change in size Change in number of cells Change into another type of cell.
Cell Aging. Aging is generally characterized by the declining ability to respond to stress, increasing homeostatic imbalance and increased risk of aging-associated.
Part II.
CELLULAR AGING AND LONGEVITY Lawrence Berkeley National Laboratory Buck Institute for Age Research.
Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
Furan-Induced Cytotoxicity, Cell Proliferation, and Tumorgenicity in Mouse Liver Dr. Glenda Moser.
Types of Genes Associated with Cancer
Oncogene Induced Senescence and secreted Cytokines.
Cancer. Cancer is a disease of the cell cycle Caused by one or more of the following: Increase in growth signals Loss of inhibitory signals In addition,
Regulation of the Cell Cycle The cell cycle can be regulated at any of the phases, but typically, variability in the length of the cell cycle is based.
Cancer Bioinformatics Tom Doman Bioinformatics Scientist Eli Lilly & Company Informatics 519 guest lecture IU Bloomington Sept
Cellular Senescence What is it? What causes it? Why is it important
Development, Stem Cells, and Cancer
Introduction to Animal Tissue culture
Genetic instability in epithelial tissues compared to stromal tissues
Targeting p53 for Oncology Drug Discovery
The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks R. Aunan Jan 1, 2 ;C Cho William 3 ;S#cod#x000F8;reide Kjetil.
p53 function and regulation in normal cells and cancer cells
Telomerase reverse transcriptase in the regulation of gene expression
Essential knowledge 3.B.2:
Regulation of the Cell Cycle & Cancer
Molecular Basis Of Cancer
Development, Stem Cells, and Cancer
Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
Environmental Carcinogenesis
Senescence in chronic liver disease: Is the future in aging?
Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer
Specific Tumor Suppressor Genes
Kanad Ghosh, Brian C. Capell  Journal of Investigative Dermatology 
p53 loss affects several steps of the metastatic process.
Presentation transcript:

Cellular senescence, cancer and aging Buck Institute for Age Research Lawrence Berkeley National Laboratory September 10, 2005 SENS2, Cambridge

Suppressing cancer costs -- aging Tumor Suppressor mechanisms Aging Phenotypes Care- takers (prevent/ repair DNA damage, mutations) Gate- keepers (eliminate/arrest damaged, mutant cells) Apoptosis Senescence Deplete proliferating/ stem cell pools ---> Tissue atrophy/degeneration Deplete proliferating/stem pools Cell dysfunction ---> loss of tissue function/homeostasis Late life phenotypes, including cancer (antagonistic pleiotropy) Longevity assurance

Cellular Senescence Suppresses Cancer Cancer cells acquire mutations that abrogate the senescence response Mutations that dampen cellular senescence greatly increase susceptibility to cancer Cellular senescence is controlled by two powerful gatekeeper tumor suppressor pathways (p53 and pRB) Mouse model, human tumor data ----> importance of cell senescence for limiting cancer progression

Short/dysfunctional telomeres (REPLICATIVE SENESCENCE) DNA Damage Oncogenes Chromatin Instability Supraphysiological Mitogenic/ Stress Signals Cellular Senescence Induced by Many (Cancer-Causing) Stimuli Irreversible arrest of cell proliferation

CELLULAR SENECENCE: Complex Senescent Phenotype Irreversible Growth Arrest Resistance to Apoptosis Altered Function/Gene Expression

The senescent phenotype: Altered pattern of gene expression Cell cycle regulation Cell structure Metabolism Biologically active secreted molecules Proteinases Cytokines Growth factors

Epithelial Cells Fibroblasts AGE INCIDENCE Mutations Senescent cells CANCER

Do senescent cells disrupt normal and/or neoplastic tissue structure/function? (effects of senescent stromal fibroblasts on epithelial cells) Jean-Philippe Coppe, Pierre Desprez, Ana Krtolica, Simona Parrinello, Christopher Patil

Senescent fibroblasts disrupt morphology and function of mammary epithelial cells BM + PreS Fb BM + Sen Fb  -casein DAPI Pre-S Fb Sen Fb  -casein E-cadherin Parrinello et al., J Cell Sci, 2005

Presenescent fibroblasts Primary duct Secondary duct Senescent fibroblasts Core Core Area Number PRIMARY SECONDARYTERTIARY Senescent fibroblasts disrupt ductal morphogenesis of normal mammary epithelial cells Parrinello et al., J Cell Sci, 2005

Senescent fibroblasts stimulate proliferation of premalignant and malignant epithelial cells Krtolica A et al., Proc Natl Acad Sci, 2001

Senescent Fibroblasts Stimulate Tumorigenesis of Premalignant Epithelial Cells In Vivo Days Tumor size (mm 3 x 10) SCp2 cells alone + Presenescent Fibroblasts + Senescent Fibroblasts Krtolica A et al., Proc Natl Acad Sci, 2001

Modeling effects of senescent cells in the mouse: Oxygen matters

Senescent phenotype of mouse fibroblasts Mouse cells undergo rapid replicative senescence in culture, despite long telomeres + telomerase Presenescent Senescen t SCp2 HaCATS1 Epithelial Cell Growth HaCATSCp2 S1 Human Fibroblasts Mouse Fibroblasts (MEFs)

Severe oxidative damage causes replicative senescence of murine cells in culture Parrinello et al., Nature Cell Biol, 2003

How do senescent cells influence the behavior of neighboring cells?

The senescence-associated secretory phenotype is conserved and complex Jean-Philippe Coppe, Pierre Desprez, Ana Krtolica, Simona Parrinello, Christopher Patil

Conclusions from antibody arrays Senescent stromal cells overexpress/secrete many cytokines, proteases, growth factors (senescence secretory phenotype) There are similarities in the secretory phenotypes of senescent human and mouse stromal cells, BUT oxygen matters There are many similarities among cells induced to senesce by different stimuli

Can the senescent phenotype be reversed without reversing the senescent growth arrest?

Parrinello et al., J Cell Sci, 2005 Senescent fibroblasts stimulate MEC ductal hyperplasia through MMP-3

THANKS! Jean-Philippe Coppe Ana Krtolica Christopher Patil Simona Parrinello (U College London) Christian Beausejour (McGill U) Pierre Desprez -- CPMC Joe Gray, Rich Neve -- LBNL Kalin Kauser -- Berlex